The Pleural Effusions Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pleural Effusions Treatment market size is estimated to be worth US$ 1566.8 million in 2021 and is forecast to a readjusted size of USD 2482.3 million by 2028 with a CAGR of 6.8% during review period. Hospitals accounting for % of the Pleural Effusions Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Thoracentesis segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pleural Effusions Treatment include B. Braun, Nouvag, Oakworks Medical, Heyer Medical, and Smith Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pleural Effusions Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
B. Braun
Nouvag
Oakworks Medical
Heyer Medical
Smith Medical
Biometrix
Maxer
Redax
Bicakcilar
Grena
Shyndec Pharmaceutical
Lepu Medical
Balance Medical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pleural Effusions Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pleural Effusions Treatment, with revenue, gross margin and global market share of Pleural Effusions Treatment from 2019 to 2022.
Chapter 3, the Pleural Effusions Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pleural Effusions Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pleural Effusions Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Pleural Effusions Treatment
1.2 Classification of Pleural Effusions Treatment by Type
1.2.1 Overview: Global Pleural Effusions Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pleural Effusions Treatment Revenue Market Share by Type in 2021
1.2.3 Thoracentesis
1.2.4 Pleurodesis
1.2.5 Pleuroperitoneal Shunt
1.3 Global Pleural Effusions Treatment Market by Application
1.3.1 Overview: Global Pleural Effusions Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Pleural Effusions Treatment Market Size & Forecast
1.5 Global Pleural Effusions Treatment Market Size and Forecast by Region
1.5.1 Global Pleural Effusions Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pleural Effusions Treatment Market Size by Region, (2017-2022)
1.5.3 North America Pleural Effusions Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Pleural Effusions Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pleural Effusions Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Pleural Effusions Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pleural Effusions Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pleural Effusions Treatment Market Drivers
1.6.2 Pleural Effusions Treatment Market Restraints
1.6.3 Pleural Effusions Treatment Trends Analysis
2 Company Profiles
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business
2.1.3 B. Braun Pleural Effusions Treatment Product and Solutions
2.1.4 B. Braun Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 B. Braun Recent Developments and Future Plans
2.2 Nouvag
2.2.1 Nouvag Details
2.2.2 Nouvag Major Business
2.2.3 Nouvag Pleural Effusions Treatment Product and Solutions
2.2.4 Nouvag Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Nouvag Recent Developments and Future Plans
2.3 Oakworks Medical
2.3.1 Oakworks Medical Details
2.3.2 Oakworks Medical Major Business
2.3.3 Oakworks Medical Pleural Effusions Treatment Product and Solutions
2.3.4 Oakworks Medical Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Oakworks Medical Recent Developments and Future Plans
2.4 Heyer Medical
2.4.1 Heyer Medical Details
2.4.2 Heyer Medical Major Business
2.4.3 Heyer Medical Pleural Effusions Treatment Product and Solutions
2.4.4 Heyer Medical Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Heyer Medical Recent Developments and Future Plans
2.5 Smith Medical
2.5.1 Smith Medical Details
2.5.2 Smith Medical Major Business
2.5.3 Smith Medical Pleural Effusions Treatment Product and Solutions
2.5.4 Smith Medical Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Smith Medical Recent Developments and Future Plans
2.6 Biometrix
2.6.1 Biometrix Details
2.6.2 Biometrix Major Business
2.6.3 Biometrix Pleural Effusions Treatment Product and Solutions
2.6.4 Biometrix Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Biometrix Recent Developments and Future Plans
2.7 Maxer
2.7.1 Maxer Details
2.7.2 Maxer Major Business
2.7.3 Maxer Pleural Effusions Treatment Product and Solutions
2.7.4 Maxer Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Maxer Recent Developments and Future Plans
2.8 Redax
2.8.1 Redax Details
2.8.2 Redax Major Business
2.8.3 Redax Pleural Effusions Treatment Product and Solutions
2.8.4 Redax Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Redax Recent Developments and Future Plans
2.9 Bicakcilar
2.9.1 Bicakcilar Details
2.9.2 Bicakcilar Major Business
2.9.3 Bicakcilar Pleural Effusions Treatment Product and Solutions
2.9.4 Bicakcilar Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Bicakcilar Recent Developments and Future Plans
2.10 Grena
2.10.1 Grena Details
2.10.2 Grena Major Business
2.10.3 Grena Pleural Effusions Treatment Product and Solutions
2.10.4 Grena Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Grena Recent Developments and Future Plans
2.11 Shyndec Pharmaceutical
2.11.1 Shyndec Pharmaceutical Details
2.11.2 Shyndec Pharmaceutical Major Business
2.11.3 Shyndec Pharmaceutical Pleural Effusions Treatment Product and Solutions
2.11.4 Shyndec Pharmaceutical Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Shyndec Pharmaceutical Recent Developments and Future Plans
2.12 Lepu Medical
2.12.1 Lepu Medical Details
2.12.2 Lepu Medical Major Business
2.12.3 Lepu Medical Pleural Effusions Treatment Product and Solutions
2.12.4 Lepu Medical Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Lepu Medical Recent Developments and Future Plans
2.13 Balance Medical
2.13.1 Balance Medical Details
2.13.2 Balance Medical Major Business
2.13.3 Balance Medical Pleural Effusions Treatment Product and Solutions
2.13.4 Balance Medical Pleural Effusions Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Balance Medical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pleural Effusions Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pleural Effusions Treatment Players Market Share in 2021
3.2.2 Top 10 Pleural Effusions Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pleural Effusions Treatment Players Head Office, Products and Services Provided
3.4 Pleural Effusions Treatment Mergers & Acquisitions
3.5 Pleural Effusions Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pleural Effusions Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Pleural Effusions Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Pleural Effusions Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Pleural Effusions Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Pleural Effusions Treatment Revenue by Type (2017-2028)
6.2 North America Pleural Effusions Treatment Revenue by Application (2017-2028)
6.3 North America Pleural Effusions Treatment Market Size by Country
6.3.1 North America Pleural Effusions Treatment Revenue by Country (2017-2028)
6.3.2 United States Pleural Effusions Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Pleural Effusions Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Pleural Effusions Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Pleural Effusions Treatment Revenue by Type (2017-2028)
7.2 Europe Pleural Effusions Treatment Revenue by Application (2017-2028)
7.3 Europe Pleural Effusions Treatment Market Size by Country
7.3.1 Europe Pleural Effusions Treatment Revenue by Country (2017-2028)
7.3.2 Germany Pleural Effusions Treatment Market Size and Forecast (2017-2028)
7.3.3 France Pleural Effusions Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pleural Effusions Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Pleural Effusions Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Pleural Effusions Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pleural Effusions Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Pleural Effusions Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Pleural Effusions Treatment Market Size by Region
8.3.1 Asia-Pacific Pleural Effusions Treatment Revenue by Region (2017-2028)
8.3.2 China Pleural Effusions Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Pleural Effusions Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Pleural Effusions Treatment Market Size and Forecast (2017-2028)
8.3.5 India Pleural Effusions Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pleural Effusions Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Pleural Effusions Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Pleural Effusions Treatment Revenue by Type (2017-2028)
9.2 South America Pleural Effusions Treatment Revenue by Application (2017-2028)
9.3 South America Pleural Effusions Treatment Market Size by Country
9.3.1 South America Pleural Effusions Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Pleural Effusions Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Pleural Effusions Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pleural Effusions Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Pleural Effusions Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Pleural Effusions Treatment Market Size by Country
10.3.1 Middle East & Africa Pleural Effusions Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Pleural Effusions Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pleural Effusions Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Pleural Effusions Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Pleural Effusions Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pleural Effusions Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pleural Effusions Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pleural Effusions Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pleural Effusions Treatment Revenue Market Share by Region (2023-2028)
Table 6. B. Braun Corporate Information, Head Office, and Major Competitors
Table 7. B. Braun Major Business
Table 8. B. Braun Pleural Effusions Treatment Product and Solutions
Table 9. B. Braun Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Nouvag Corporate Information, Head Office, and Major Competitors
Table 11. Nouvag Major Business
Table 12. Nouvag Pleural Effusions Treatment Product and Solutions
Table 13. Nouvag Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Oakworks Medical Corporate Information, Head Office, and Major Competitors
Table 15. Oakworks Medical Major Business
Table 16. Oakworks Medical Pleural Effusions Treatment Product and Solutions
Table 17. Oakworks Medical Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Heyer Medical Corporate Information, Head Office, and Major Competitors
Table 19. Heyer Medical Major Business
Table 20. Heyer Medical Pleural Effusions Treatment Product and Solutions
Table 21. Heyer Medical Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Smith Medical Corporate Information, Head Office, and Major Competitors
Table 23. Smith Medical Major Business
Table 24. Smith Medical Pleural Effusions Treatment Product and Solutions
Table 25. Smith Medical Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Biometrix Corporate Information, Head Office, and Major Competitors
Table 27. Biometrix Major Business
Table 28. Biometrix Pleural Effusions Treatment Product and Solutions
Table 29. Biometrix Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Maxer Corporate Information, Head Office, and Major Competitors
Table 31. Maxer Major Business
Table 32. Maxer Pleural Effusions Treatment Product and Solutions
Table 33. Maxer Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Redax Corporate Information, Head Office, and Major Competitors
Table 35. Redax Major Business
Table 36. Redax Pleural Effusions Treatment Product and Solutions
Table 37. Redax Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Bicakcilar Corporate Information, Head Office, and Major Competitors
Table 39. Bicakcilar Major Business
Table 40. Bicakcilar Pleural Effusions Treatment Product and Solutions
Table 41. Bicakcilar Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Grena Corporate Information, Head Office, and Major Competitors
Table 43. Grena Major Business
Table 44. Grena Pleural Effusions Treatment Product and Solutions
Table 45. Grena Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Shyndec Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Shyndec Pharmaceutical Major Business
Table 48. Shyndec Pharmaceutical Pleural Effusions Treatment Product and Solutions
Table 49. Shyndec Pharmaceutical Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Lepu Medical Corporate Information, Head Office, and Major Competitors
Table 51. Lepu Medical Major Business
Table 52. Lepu Medical Pleural Effusions Treatment Product and Solutions
Table 53. Lepu Medical Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Balance Medical Corporate Information, Head Office, and Major Competitors
Table 55. Balance Medical Major Business
Table 56. Balance Medical Pleural Effusions Treatment Product and Solutions
Table 57. Balance Medical Pleural Effusions Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Pleural Effusions Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Pleural Effusions Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Pleural Effusions Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Pleural Effusions Treatment Players Head Office, Products and Services Provided
Table 62. Pleural Effusions Treatment Mergers & Acquisitions in the Past Five Years
Table 63. Pleural Effusions Treatment New Entrants and Expansion Plans
Table 64. Global Pleural Effusions Treatment Revenue (USD Million) by Type (2017-2022)
Table 65. Global Pleural Effusions Treatment Revenue Share by Type (2017-2022)
Table 66. Global Pleural Effusions Treatment Revenue Forecast by Type (2023-2028)
Table 67. Global Pleural Effusions Treatment Revenue by Application (2017-2022)
Table 68. Global Pleural Effusions Treatment Revenue Forecast by Application (2023-2028)
Table 69. North America Pleural Effusions Treatment Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Pleural Effusions Treatment Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Pleural Effusions Treatment Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Pleural Effusions Treatment Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Pleural Effusions Treatment Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Pleural Effusions Treatment Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Pleural Effusions Treatment Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Pleural Effusions Treatment Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Pleural Effusions Treatment Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Pleural Effusions Treatment Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Pleural Effusions Treatment Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Pleural Effusions Treatment Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Pleural Effusions Treatment Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Pleural Effusions Treatment Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Pleural Effusions Treatment Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Pleural Effusions Treatment Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Pleural Effusions Treatment Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Pleural Effusions Treatment Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Pleural Effusions Treatment Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Pleural Effusions Treatment Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Pleural Effusions Treatment Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Pleural Effusions Treatment Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Pleural Effusions Treatment Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Pleural Effusions Treatment Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Pleural Effusions Treatment Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Pleural Effusions Treatment Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Pleural Effusions Treatment Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Pleural Effusions Treatment Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Pleural Effusions Treatment Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Pleural Effusions Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pleural Effusions Treatment Picture
Figure 2. Global Pleural Effusions Treatment Revenue Market Share by Type in 2021
Figure 3. Thoracentesis
Figure 4. Pleurodesis
Figure 5. Pleuroperitoneal Shunt
Figure 6. Pleural Effusions Treatment Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Pleural Effusions Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Pleural Effusions Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pleural Effusions Treatment Revenue Market Share by Region (2017-2028)
Figure 13. Global Pleural Effusions Treatment Revenue Market Share by Region in 2021
Figure 14. North America Pleural Effusions Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Pleural Effusions Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Pleural Effusions Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Pleural Effusions Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Pleural Effusions Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Pleural Effusions Treatment Market Drivers
Figure 20. Pleural Effusions Treatment Market Restraints
Figure 21. Pleural Effusions Treatment Market Trends
Figure 22. B. Braun Recent Developments and Future Plans
Figure 23. Nouvag Recent Developments and Future Plans
Figure 24. Oakworks Medical Recent Developments and Future Plans
Figure 25. Heyer Medical Recent Developments and Future Plans
Figure 26. Smith Medical Recent Developments and Future Plans
Figure 27. Biometrix Recent Developments and Future Plans
Figure 28. Maxer Recent Developments and Future Plans
Figure 29. Redax Recent Developments and Future Plans
Figure 30. Bicakcilar Recent Developments and Future Plans
Figure 31. Grena Recent Developments and Future Plans
Figure 32. Shyndec Pharmaceutical Recent Developments and Future Plans
Figure 33. Lepu Medical Recent Developments and Future Plans
Figure 34. Balance Medical Recent Developments and Future Plans
Figure 35. Global Pleural Effusions Treatment Revenue Share by Players in 2021
Figure 36. Pleural Effusions Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Pleural Effusions Treatment Revenue Market Share in 2021
Figure 38. Global Top 10 Players Pleural Effusions Treatment Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Pleural Effusions Treatment Revenue Share by Type in 2021
Figure 41. Global Pleural Effusions Treatment Market Share Forecast by Type (2023-2028)
Figure 42. Global Pleural Effusions Treatment Revenue Share by Application in 2021
Figure 43. Global Pleural Effusions Treatment Market Share Forecast by Application (2023-2028)
Figure 44. North America Pleural Effusions Treatment Sales Market Share by Type (2017-2028)
Figure 45. North America Pleural Effusions Treatment Sales Market Share by Application (2017-2028)
Figure 46. North America Pleural Effusions Treatment Revenue Market Share by Country (2017-2028)
Figure 47. United States Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Pleural Effusions Treatment Sales Market Share by Type (2017-2028)
Figure 51. Europe Pleural Effusions Treatment Sales Market Share by Application (2017-2028)
Figure 52. Europe Pleural Effusions Treatment Revenue Market Share by Country (2017-2028)
Figure 53. Germany Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Pleural Effusions Treatment Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Pleural Effusions Treatment Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Pleural Effusions Treatment Revenue Market Share by Region (2017-2028)
Figure 61. China Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Pleural Effusions Treatment Sales Market Share by Type (2017-2028)
Figure 68. South America Pleural Effusions Treatment Sales Market Share by Application (2017-2028)
Figure 69. South America Pleural Effusions Treatment Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Pleural Effusions Treatment Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Pleural Effusions Treatment Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Pleural Effusions Treatment Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Pleural Effusions Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source